New: Biosimilars strategies introduced.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
May 23, 2018 - The FDA announced that over-the-counter (OTC) benzocaine products should not be used to treat infants and children < 2 years of age.
Download PDF
Return to publications
